On August 26, 2026 Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, reported that management will participate in the following upcoming investor events:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 21st Annual Healthcare Conference
Format: 1-on-1 Meetings
Date: Wednesday, September 9, 2026
Location: Boston, MA

2026 Cantor Global Healthcare Conference
Format: Fireside Chat and 1-on-1 Meetings
Date: Thursday, September 10, 2026
Time: 10:55 AM ET
Location: New York, NY

H.C. Wainwright 28th Annual Global Investment Conference
Format: Company Presentation and 1-on-1 Meetings
Date: Monday, September 14, 2026
Time: 4:30 PM ET
Location: New York, NY

The corporate presentation and H.C. Wainwright webcast will be accessible on Tvardi Investors’ website. A replay of the webcast will be available for approximately 90 days following the conference.

(Press release, Tvardi Therapeutics, AUG 26, 2026, View Source [SID1234670376])